Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.3.1681

Tissue Expression, Serum and Salivary Levels of IL-10 in Patients with Head and Neck Squamous Cell Carcinoma  

Hamzavi, Marzieh (Department of Oral and Maxillofacial Pathology, Shiraz University of Medical Sciences)
Tadbir, Azadeh Andisheh (Department of Oral and Maxillofacial Pathology, Shiraz University of Medical Sciences)
Rezvani, Gita (Department of Oral and Maxillofacial Pathology, Shiraz University of Medical Sciences)
Ashraf, Mohammad Javad (Department of Pathology, School of Medicine, Shiraz University of Medical Sciences)
Fattahi, Mohammad Javad (Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences)
Khademi, Bijan (Department of Otolaryngology, Khalili Hospital, Shiraz University of Medical Sciences)
Sardari, Yasaman (Department of Oral and Maxillofacial Pathology, Shiraz University of Medical Sciences)
Jeirudi, Naghmeh (School of Dentistry, Shiraz University of Medical Sciences)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.3, 2013 , pp. 1681-1685 More about this Journal
Abstract
Background: Head and neck SCC is a common cancer related to various factors. IL-10, a pleiotropic cytokine produced by macrophages, T-helper-2 cells, and B lymphocytes, is thought to play a potential pathogenetic or therapeutic role in a number of human conditions, such as inflammation, autoimmunity and cancer. The present study was designed to evaluate the relation between tissue expression, serum and salivary levels of IL-10 in head and neck squamous cell carcinomas (HNSCCs) and their correlation with clinicopathologic features. Materials and Methods: Samples were collected from 30 patients with HNSCCs and 24 healthy volunteers. IHC analysis was used to examine the tissue expression and ELISA was employed to measure serum and salivary levels. Results: Our study showed tissue expression of IL-10 to be significantily higher in patients (P: 0.001), but there was no relation between tissue expression, serum and salivary levels of the marker (P>0.05). Also except for a positive correlation between tissue expression of IL-10 and stage (P: 0.044), there was no relation between this marker and clinicopathologic features. There was no correlation between serum and salivary levels in either patients or controls. Conclusions: It seems there is no correlation between level of IL-10 in serum and saliva and this marker in saliva and serum does not reflect tissue expression.
Keywords
Interleukin-10; head and neck SCC; serum; saliva;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alhamarneh O, Agada F, Madden L, et al (2010). Serum IL-10 and Circulating CD4+CD25inch regulatory T cell numvers aspredictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head Neck, 10, 415-23.
2 Asadullah S, Sterry W, Volk HD (2003). Interleukin-10 Therapy-Review of a new Approch. Pharmacol Rev, 55, 241-69.   DOI   ScienceOn
3 Berman RM, Suzuki T, Tahara H, et al (1996). Systemic administration of cellular IL-10 induces an effective, specific c, and long-lived immune response against established tymors in mice. J Immunol, 157, 231-8.
4 Berzofsky JA, Terabe M (2009). The contrasing roles of NKT cells in tumor immunity. Curr Mol Med, 9, 667-72.   DOI
5 Brooks M, Wang J, Li Y, et al (2008). Salivary protein factors are elevated in breast cancer patients. Nip Publish Access Author Manuscript, 1, 75-378.
6 Cervenak L, Morbidelli L, Donati D, et al (2000). Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by Interleukin-10. Blood, 96, 2568-73.
7 Chandler S, Rassekh C, Roadman S, et al (2002). Immunohistochemical localization of Interleukin-10 in human oral and pharyngeal carcinoma. Laryngoscope, 112, 808-15   DOI   ScienceOn
8 DiLillo DJ, Matsushita T, Tedder TF (2010). B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci, 1183, 38-57.   DOI   ScienceOn
9 Fujieda SH, Sunaga H, Tsuzuki H, et al (1999). IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. Cancer Letter, 136, 1-9.   DOI   ScienceOn
10 Hoffmann TK, Sonkoly E, Homey B (2007). Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck. Head Neck, 29, 472-8.   DOI   ScienceOn
11 Lathers DM, Young MR (2004). Increased aberrance of cytokine expression in plasma of patient with more advanced squamous cell carcinoma of the head and neck. Cytokine, 25, 220-8.   DOI   ScienceOn
12 Linkov F, Lisovich A, Yurkovetsky Z (2007). Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling. Cancer Epidemiol Biomarkers Prev, 16, 102-7.   DOI   ScienceOn
13 Liu J, Song B, Wang JL, et al (2011). Polymorphisms of Interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol, 17, 1362-7   DOI   ScienceOn
14 Nelson EL, Wenzel LB, Osann K, et al (2008). Stress, immunity and cervical cancer: biobehavioral outcomes of a randomized clinical trial. Clin Cancer Res, 14, 2111-8.   DOI   ScienceOn
15 Sabat R, Grutz G, Warszawska K, et al (2010). Biology of interleukin-10. Cytokine Growth factor REV, 21, 331-44.   DOI   ScienceOn
16 Shang ZJ, Li JR, Li ZB (2007). Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. J Oral Maxillofact Surg, 65, 17-21.   DOI   ScienceOn
17 Sparano A, Lathers DM, Achille N, et al (2004). Modulation of TH1 and TH2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg, 131, 573-6.   DOI   ScienceOn
18 Toiyama Y, Miki C, Inoue Y, et al (2010). Loss of tissue expression of IL-10 promotes the disease progression of colorectal carcinoma. Surg Today, 46, 46-53.
19 Stearns ME, Rhim J, Wang M (1999). Interleukin-10(IL-10) inhibition of primary human prostate cellinduced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res, 5, 189-96.
20 Teles RP, Likhari V, Socransky SS, et al (2009). Salivary cytokine levels in chronic periodontitis and periodomtally healthy subjects. A cross-sectional study. J Periodontal Res, 44, 411-7.   DOI   ScienceOn
21 Wozniak KL, Arribas A, Leigh JE, et al (2002). Inhibitory effects of whole and parotid saliva on immunomodulators. Oral Microbiol Immunol, 17, 100-7.   DOI
22 Zheng LM, Ojcius DM, Garaud F, et al (1996). Interleukin-10 inhibits tumor metastasis through an NK cell dependent mechanism. J Exp Med, 184, 579-84.   DOI